$ANTX
AN2 Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$4.89
▼-0.20%-$0.010
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAN2 Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ANTX up today? It is at $4.89 (+0.00%), and our scanner flagged it 30 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ANTX spikes, and full due diligence on ANTX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ANTX 30 times in the last 30 days. Create a free account to track $ANTX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ANTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ANTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Trenor Cameron C. Iii Officer | Acquired (grant/award) | +117K 0.3% of company | n/a | 117K | n/a | Sep 15, 26 |
Readnour Robin Shane Director | Sold (automatic/other) | -1K | sold <0.1% | 1.18M | $7K at $6.02 | Sep 9, 26 |
Readnour Robin Shane Director | Sold (automatic/other) | -10K 0.03% of company | sold 0.8% | 1.18M | $60K at $6.02 | Sep 8, 26 |
Readnour Robin Shane Director | Sold (automatic/other) | -6K 0.02% of company | sold 1.1% | 563K | $37K at $6.07 | Sep 3, 26 |
Fitzpatrick Margaret M Director | Bought (open market) | +2K | added 24% | 11K | $12K at $5.53 | Sep 1, 26 |
Williams Sarah Joanne Officer | Sold (automatic/other) | -272 | sold 0.4% | 66K | $2K at $5.53 | Sep 1, 26 |
Readnour Robin Shane Director | Sold (automatic/other) | -35K 0.09% of company | sold 2.9% | 1.20M | $213K at $6.01 | Aug 17, 26 |
Zakrzewski Joseph S Director | Sold (automatic/other) | -406K 1.1% of company | n/a | n/a | n/a | Aug 14, 26 |
Martin Patricia A. Director | Acquired (grant/award) | +766 | added 4.2% | 19K | n/a | Jul 10, 26 |
Marks Gilbert Lynn Director | Acquired (grant/award) | +3K | added 3.5% | 82K | n/a | Jul 10, 26 |
Aziz Kabeer Director | Acquired (grant/award) | +3K | added 5.1% | 59K | n/a | Jul 10, 26 |
Eizen Joshua M Officer | Sold (automatic/other) | -6K 0.02% of company | sold 2.8% | 207K | $25K at $4.17 | Jul 8, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ANTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ANTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ANTX last traded at $4.89, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
AN2 Therapeutics, Inc. Common Stock (ANTX) is next expected to report earnings on Wednesday, November 11, 2026, about 54 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ANTX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ANTX 30 times in the last 30 days.
ANTX (AN2 Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $202M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ANTX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ANTX discussion
Sign in to ask a question or join the discussion.